Is oxytocin a therapeutic factor for ischemic heart disease?

@article{Alizadeh2013IsOA,
  title={Is oxytocin a therapeutic factor for ischemic heart disease?},
  author={Ali Mohammad Alizadeh and Parasto Mirzabeglo},
  journal={Peptides},
  year={2013},
  volume={45},
  pages={66-72}
}

Figures from this paper

Therapeutic Potential of Oxytocin in Atherosclerotic Cardiovascular Disease: Mechanisms and Signaling Pathways

The current understanding of the protective effect of OT against varieties of atherosclerotic etiologies as well as the approaches and underlying mechanisms of these effects are reviewed.

The Role of Oxytocin in Cardiovascular Protection

Evidence indicates that oxytocin treatment improves cardiac work, reduces apoptosis and inflammation, and increases scar vascularization, as well as cardioprotection, by reducing the inflammatory response and improving cardiovascular and metabolic function.

Oxytocin and cardioprotection in diabetes and obesity

It is shown that chronic OT treatment prevents the development of diabetic cardiomyopathy in the db/db mouse and may help replace lost CMs by stimulating the in situ differentiation of cardiac stem cells into functional mature CMs.

References

SHOWING 1-10 OF 107 REFERENCES

An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials.

Oxytocin exerts protective effects on in vitro myocardial injury induced by ischemia and reperfusion.

The data suggest that the negative chronotropic action of oxytocin participates in its protective effects on ischemia-reperfusion-induced myocardial injury, and demonstrates an attenuation of the infarct size in oxytocIn-treated hearts, indicating a cardioprotective effect of Oxytocin.

Epsilon protein kinase C as a potential therapeutic target for the ischemic heart.

Preconditioning effects of oxytocin in reducing cardiac arrhythmias in a rat heart regional ischemia-reperfusion model

It is demonstrated that preconditioning with oxytocin reduced ischemia -reperfusion- induced ventricular arrhythmias and its signaling pathways are probably mediated by rough mitochondrial permeability transition pore and reactive oxygen species.

Anti-inflammatory effect of oxytocin in rat myocardial infarction

Results indicate that continuous OT delivery reduces inflammation and apoptosis in infarcted and remote myocardium, thus improving function in the injured heart.

Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities.

  • H. Otani
  • Medicine, Biology
    Antioxidants & redox signaling
  • 2008
The first purpose of this review is to facilitate understanding of pathophysiology of I/R injury and the mechanisms of cardioprotection afforded by IPC in the normal heart, and the problems and opportunities for successful bench-to-bedside translation of I PC in the diseased hearts.

Reactive Oxygen Species as Mediators of Cardiac Injury and Protection: The Relevance to Anesthesia Practice

Reactive oxygen species (ROS) are central to cardiac ischemic and reperfusion injury. They contribute to myocardial stunning, infarction and apoptosis, and possibly to the genesis of arrhythmias.

Effect of pre-treatment with oxytocin on cardiac enzymes in regional ischemia- reperfusion injury induced in the rat heart

The present study demonstrates that oxytocin cardioprotective effects are complex and its signaling pathways may mediate through mKATP channels, mPTP, PKC activation and increase ROS.
...